Condition
Myxofibrosarcoma (MFS) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Myxofibrosarcoma (MFS) clinical trials that are recruiting, at sites in 4 countries (most in Norway (1), Australia (1), United Kingdom (1)). By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
Three-week preoperative proton versus X-ray radiotherapy for localized soft tissue sarcoma
This trial tests whether selecting proton rather than standard X‑ray radiotherapy before surgery for adults with localized soft tissue sarcoma can lower long-term radiation side effects without increasing surgical complications.
-
Investigating OKN4395 and Pembrolizumab for Solid Tumors
This study is testing a new drug called OKN4395, alone and with another drug called pembrolizumab, to see if it can help people with solid tumors who have run out of other treatment options.
Related topics
Quick answers
How many Myxofibrosarcoma (MFS) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Norway (1 trial), Australia (1 trial), United Kingdom (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.